Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directionsNaveen Vasudev(Institute of Cancer Research), Andrew R. Reynolds(Cancer Research UK)AngiogenesisJanuary 31, 201410.1007/s10456-014-9420-yCited by 732SaveCiteExport RISWatch citationsRelated PapersElevated Flk1 (Vascular Endothelial Growth Factor Receptor 2) Signaling Mediates Enhanced Angiogenesis in β3-Integrin–Deficient Mice|Cancer Research|2004|153